-transparent.png){kind=logo}
The presence of circulating serum antinuclear antibodies (ANA) directed against various nuclear structures is a hallmark of systemic rheumatic diseases. These diseases are characterized by overlapping clinical features and the diagnosis is not always clear-cut. Each disease has a profile of ANA specificities which is more or less specific to that disease. Therefore serological tests that define the precise specificities of ANA are of great importance for establishing the diagnosis.
Related Publications
G K Endresen, and
O J Mellbye
January 1977,
Reports on rheumatic diseases,
G K Endresen, and
O J Mellbye
June 2020,
Zeitschrift fur Rheumatologie,
G K Endresen, and
O J Mellbye
January 1985,
Bulletin on the rheumatic diseases,
G K Endresen, and
O J Mellbye
October 1975,
Annals of internal medicine,
G K Endresen, and
O J Mellbye
January 1994,
Lakartidningen,
G K Endresen, and
O J Mellbye
June 1984,
British medical journal (Clinical research ed.),
G K Endresen, and
O J Mellbye
March 1981,
Klinische Wochenschrift,
G K Endresen, and
O J Mellbye
January 1992,
Duodecim; laaketieteellinen aikakauskirja,
G K Endresen, and
O J Mellbye
August 1996,
Annals of medicine,
G K Endresen, and
O J Mellbye
April 2013,
Archives of disease in childhood. Education and practice edition,
